Logo image of SHCR

SHARECARE INC (SHCR) Stock Fundamental Analysis

NASDAQ:SHCR - Nasdaq - US81948W1045 - Common Stock - Currency: USD

1.43  -0.01 (-0.35%)

After market: 1.43 0 (0%)

Fundamental Rating

3

SHCR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. While SHCR seems to be doing ok healthwise, there are quite some concerns on its profitability. SHCR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SHCR has reported negative net income.
SHCR had a negative operating cash flow in the past year.
SHCR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SHCR reported negative operating cash flow in multiple years.
SHCR Yearly Net Income VS EBIT VS OCF VS FCFSHCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -24.25%, SHCR perfoms like the industry average, outperforming 54.05% of the companies in the same industry.
With a Return On Equity value of -31.01%, SHCR perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
Industry RankSector Rank
ROA -24.25%
ROE -31.01%
ROIC N/A
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHCR Yearly ROA, ROE, ROICSHCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

SHCR has a Gross Margin of 44.04%. This is in the lower half of the industry: SHCR underperforms 67.57% of its industry peers.
In the last couple of years the Gross Margin of SHCR has declined.
SHCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
SHCR Yearly Profit, Operating, Gross MarginsSHCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

SHCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SHCR has been reduced compared to 1 year ago.
The debt/assets ratio for SHCR is higher compared to a year ago.
SHCR Yearly Shares OutstandingSHCR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M
SHCR Yearly Total Debt VS Total AssetsSHCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

SHCR has an Altman-Z score of 0.73. This is a bad value and indicates that SHCR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SHCR (0.73) is comparable to the rest of the industry.
SHCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACCN/A
WACC9.12%
SHCR Yearly LT Debt VS Equity VS FCFSHCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.02 indicates that SHCR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.02, SHCR is in line with its industry, outperforming 56.76% of the companies in the same industry.
A Quick Ratio of 2.02 indicates that SHCR has no problem at all paying its short term obligations.
SHCR's Quick ratio of 2.02 is in line compared to the rest of the industry. SHCR outperforms 59.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
SHCR Yearly Current Assets VS Current LiabilitesSHCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SHCR have decreased strongly by -11.43% in the last year.
SHCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.11%.
SHCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.63% yearly.
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%

3.2 Future

Based on estimates for the next years, SHCR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.33% on average per year.
The Revenue is expected to grow by 0.95% on average over the next years.
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHCR Yearly Revenue VS EstimatesSHCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
SHCR Yearly EPS VS EstimatesSHCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHCR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SHCR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHCR Price Earnings VS Forward Price EarningsSHCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHCR Per share dataSHCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.49%
EPS Next 3Y11.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SHCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHARECARE INC

NASDAQ:SHCR (10/21/2024, 8:00:02 PM)

After market: 1.43 0 (0%)

1.43

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-09 2024-08-09/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners38.79%
Inst Owner Change-6.94%
Ins Owners0.1%
Ins Owner Change0%
Market Cap531.79M
Analysts48.89
Price Target1.46 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.56%
Min EPS beat(2)-68.07%
Max EPS beat(2)-47.05%
EPS beat(4)1
Avg EPS beat(4)-39.36%
Min EPS beat(4)-68.07%
Max EPS beat(4)8.5%
EPS beat(8)1
Avg EPS beat(8)-38.89%
EPS beat(12)2
Avg EPS beat(12)-55.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.26%
Min Revenue beat(2)-12.09%
Max Revenue beat(2)-2.43%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-12.09%
Max Revenue beat(4)-2.22%
Revenue beat(8)3
Avg Revenue beat(8)-2.77%
Revenue beat(12)5
Avg Revenue beat(12)-2.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 4.32
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS1.09
BVpS1.18
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.25%
ROE -31.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.04%
FCFM N/A
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.08%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z 0.73
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)6.08%
Cap/Depr(5y)6.54%
Cap/Sales(3y)0.6%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
EBIT growth 1Y-15.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.69%
EBIT Next 3Y30.06%
EBIT Next 5YN/A
FCF growth 1Y82.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.64%
OCF growth 3YN/A
OCF growth 5YN/A